These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Bone gammagraphy in the diagnosis of uremic renal osteodystrophy]. Marco Franco JE; Alarcón Zurita A; Peñafiel A; Pizá Buñola C; Morey Molina A; Bestard Palmer J; Mairata Bosch S; Dalmau Diana M Rev Clin Esp; 1982 Mar; 164(5):329-32. PubMed ID: 7100549 [No Abstract] [Full Text] [Related]
23. Metabolic abnormalities in uremia. Wilson DM Med Clin North Am; 1971 Nov; 55(6):1381-96. PubMed ID: 4942869 [No Abstract] [Full Text] [Related]
24. [Bone biopsy in renal osteodystrophy]. Serrano S; Mariñoso ML Med Clin (Barc); 1991 Apr; 96(15):573-4. PubMed ID: 2051814 [No Abstract] [Full Text] [Related]
25. Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia. Ishii H; Wada M; Furuya Y; Nagano N; Nemeth EF; Fox J Bone; 2000 Feb; 26(2):175-82. PubMed ID: 10678413 [TBL] [Abstract][Full Text] [Related]
26. Renal osteodystrophy--pathogenesis and treatment. Cushner HM; Adams ND Am J Med Sci; 1985 Dec; 290(6):234-45. PubMed ID: 3909812 [TBL] [Abstract][Full Text] [Related]
27. Quantitative histological studies on the pathogenesis of uremic bone disease. Sherrard DJ; Baylink DJ; Wergedal JE; Maloney NA J Clin Endocrinol Metab; 1974 Jul; 39(1):119-35. PubMed ID: 4835127 [No Abstract] [Full Text] [Related]
28. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus. Dunstan CR; Hills E; Norman AW; Bishop JE; Mayer E; Wong SY; Johnson JR; George CR; Collett P; Kalowski S Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311 [TBL] [Abstract][Full Text] [Related]
29. Review: Renal osteodystrophy--pathogenesis and treatment. Cushner HM; Adams ND Am J Med Sci; 1986 Apr; 291(4):264-75. PubMed ID: 3518448 [TBL] [Abstract][Full Text] [Related]
30. Pathogenesis of uremic osteodystrophy. Agus ZS; Goldberg M Radiol Clin North Am; 1972 Dec; 10(3):545-56. PubMed ID: 4566892 [No Abstract] [Full Text] [Related]
31. Can renal bone disease be prevented? Shaldon S Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119 [No Abstract] [Full Text] [Related]
32. Evolution of renal osteodystrophy: correlation of bone histomorphometry and serum mineral and immunoreactive parathyroid hormone values before and after treatment with calcium carbonate or 25-hydroxycholecalciferol. Bordier PJ; Marie PJ; Arnaud CD Kidney Int Suppl; 1975 Jan; (2):102-12. PubMed ID: 1057669 [No Abstract] [Full Text] [Related]
34. Bone biopsy in renal osteodystrophy. Rogers S J Pathol; 1993 Nov; 171(3):155-6. PubMed ID: 8277364 [No Abstract] [Full Text] [Related]
35. The use of high calcium dialysate in the treatment of renal osteomalacia. Evans RA; Somerville PJ Aust N Z J Med; 1976 Feb; 6(1):10-5. PubMed ID: 1065293 [TBL] [Abstract][Full Text] [Related]
36. [Histological classification of uremic bone disease and clinical significance of bone biopsy]. Zhu JM; Alfrey AC; Huffer WE Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):444-7. PubMed ID: 8275820 [TBL] [Abstract][Full Text] [Related]
37. Recommendations for the treatment of renal osteodystrophy in dialysis patients. Slatopolsky E Kidney Int Suppl; 1975 Jan; (2):253-5. PubMed ID: 169423 [No Abstract] [Full Text] [Related]
38. [Fine structure of mast cells in iliac crest biopsies during renal osteodystrophy]. Rebel A; Malkani K Pathol Biol (Paris); 1974 Mar; 22(3):221-8. PubMed ID: 4603545 [No Abstract] [Full Text] [Related]